Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial
Open Access
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 25 (11) , 2160-2166
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 30 references indexed in Scilit:
- Rapid Quantification of the Latent Reservoir for HIV-1 Using a Viral Outgrowth AssayPLOS Pathogens, 2013
- Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantationBlood, 2011
- HIV Status Does Not Affect the Outcome of Autologous Stem Cell Transplantation (ASCT) for Non-Hodgkin Lymphoma (NHL)Transplantation and Cellular Therapy, 2010
- Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we canBlood, 2009
- High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factorsBlood, 2009
- Allogeneic Hematopoietic Cell Transplantation in Human Immunodeficiency Virus–Positive Patients with Hematologic Disorders: A Report from the Center for International Blood and Marrow Transplant ResearchTransplantation and Cellular Therapy, 2009
- A Scheme for Defining Cause of Death and Its Application in the T Cell Depletion TrialTransplantation and Cellular Therapy, 2007
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007
- HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantationExperimental Hematology, 2005
- Low-Dose Compared with Standard-Dose m-BACOD Chemotherapy for Non-Hodgkin's Lymphoma Associated with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1997